Cargando…
Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is one of the leading causes of death in the US and there is no validated drugs to stop, slow or prevent AD. Despite tremendous effort on biomarker discovery, existing findings are mostly individual biomarkers and provide limited insights into the transcriptomic...
Autores principales: | Upadhyaya, Yurika, Xie, Linhui, Salama, Paul, Cao, Sha, Nho, Kwangsik, Saykin, Andrew J., Yan, Jingwen, Alzheimer’s Disease Neuroimaging Initiative, for the |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118822/ https://www.ncbi.nlm.nih.gov/pubmed/32241275 http://dx.doi.org/10.1186/s12920-020-0689-y |
Ejemplares similares
-
Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
por: Fleisher, Adam S., et al.
Publicado: (2009) -
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
por: De Velasco Oriol, Javier, et al.
Publicado: (2019) -
The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer’s Disease
por: Huang, Chun-Chao, et al.
Publicado: (2018) -
Topological Measurements of DWI Tractography for Alzheimer's Disease Detection
por: Amoroso, Nicola, et al.
Publicado: (2017) -
Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
por: Nozadi, Seyed Hossein, et al.
Publicado: (2018)